Aesthetic device company BTL Aesthetics has unveiled its new non-invasive brain stimulation device EXOMIND.
This FDA-cleared treatment is designed to stimulate key areas of the brain involved in emotional regulation, cognitive function and self-control, according to the company. They shared that by activating neural pathways, it helps restore healthy brain activity and enhances neural connectivity, improving mental and emotional wellbeing.
Filip Donner, director of BTL Aesthetics, commented, “EXOMIND technology demonstrates our commitment to wellness by delivering natural, innovative solutions that empower individuals to reach their full potential. This patient-friendly therapy aligns with our vision of promoting holistic health. Unlike conventional treatments, it provides a natural approach to mental wellness, fostering brain resilience without the side effects often associated with pharmaceuticals.”
